Matthew Donley's Insider Trades & SAST Disclosures
Matthew Donley's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 135,567 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Donley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Matthew Donley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 135,567 | 805,358 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 126,416 | 126,416 | - | - | Employee Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 82,781 | 669,791 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 28 Feb 2025 | 65,902 | 739,456 (0%) | 0% | 8 | 527,216 | Common Stock |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.92 per share. | 28 Feb 2025 | 58,991 | 680,465 (0%) | 0% | 7.9 | 467,209 | Common Stock |
| Aurinia Pharmaceuticals Inc | Matthew Donley | EVP, Ops & Strategy | Sale of securities on an exchange or to another person at price $ 5.51 per share. | 06 Mar 2024 | 40,665 | 584,072 (0%) | 0% | 5.5 | 224,064 | Common Stock |
| Aurinia Pharmaceuticals Inc | Donley Matthew | EVP, Ops & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 216,666 | 624,737 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | EVP, Ops & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 271,134 | 403,141 (0%) | 0% | - | Common Stock | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internal Operations | Purchase of securities on an exchange or from another person at price $ 4.66 per share. | 21 Nov 2022 | 10,000 | 27,927 (0%) | 0% | 4.7 | 46,600 | Common Stock |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internl Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 178,063 | 178,063 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internl Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 104,080 | 104,080 | - | - | Restricted Stock Unit | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internl Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 8,500 | 19,276 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internl Operations | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 02 Mar 2022 | 3,052 | 16,224 (0%) | 0% | 12.0 | 36,655 | Common Stock |
| Aurinia Pharmaceuticals Inc | Matthew Donley | Ex VP, Internl Operations | Purchase of securities on an exchange or from another person at price $ 10.07 per share. | 11 May 2021 | 9,900 | 9,900 (0%) | 0% | 10.1 | 99,739 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges